In one paragraphReview in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
4 authors.
Nawal Abdul-BakiDepartment of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0009-0005-4389-4715 Reimi NavarroDepartment of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0009-0008-3035-9213 Jieh-Juen YuDepartment of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0000-0001-8901-3366 Chiung-Yu HungDepartment of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0000-0003-1091-3420 Funding
Screening Repurposing Libraries for the Identification of Drugs with Novel anti-Coccidioidal ActivityU19AI166761 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI CHIUNG-YU HUNG · 2022 to 2026
$8.1MLarge Scale T Cell Epitope Discovery75N93019C00064 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GAGE, KASIA · 2019 to 2024
$6.3MDevelopment of a multivalent vaccine against Coccidioides infectionR01AI135005 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI HUNG, CHIUNG-YU · 2018 to 2022
$1.9MMMI-T32 Training Pre-doctoral Scientists in Molecular Microbiology and Immunology at UTSAT32AI184340 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI Astrid E Cardona, Jose L. Lopez-Ribot · 2024 to 2026
$463kNational Institute of Allergy and Infectious Diseases R01AI135005National Institute of Allergy and Infectious Diseases U19AI166761NIAID NIH HHS R01 AI135005NIAID NIH HHS T32 AI184340NIAID NIH HHS U19 AI166761NIH HHS 75N93019C00064
6 · The paper itselfAbstract
Coccidioidomycosis (CM) is a fungal infection caused by the inhalation of airborne arthroconidia released by
Indexed as
adjuvantsCoccidioidesimmunotherapymRNAorganoidsvaccinesValley Fever
Identifiers
PMID41893146
PMCPMC13028310
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390